USMJ - North American Cannabis Holdings Releases Shareholder Update
May 08 2018 - 9:33AM
InvestorsHub NewsWire
Dallas, TX -- May 8, 2018 -- InvestorHub
NewsWire -- North
American Cannabis Holdings, Inc. (USOTC:
USMJ) today released a shareholder update from the Company’s
CEO, Steven Rash:
Dear Shareholders-
North American Cannabis Holdings has been a
little quiet on the news front since announcing that we have been
approached by a party interested in acquiring the company.
We’re still engaged with the interested party, but it’s also still
premature to release any news regarding the potential of such a
transaction. Accordingly, we’ll probably be quiet on the news
front a little longer.
Here’s what I will say: North American
Cannabis Holdings has amassed a number of cannabis sector assets
and experiences since entering the space in 2013. Even more
valuable, the company has built a substantial following and it is
the company’s shareholders that are the most valuable asset.
The party interested in potentially acquiring North American
Cannabis Holdings has specific interests in a number of the
company’s assets and experiences, but the company’s shareholder
base stands out among the most prominent
interests.
I believe there is a potential transaction here
that can substantially improve North American Cannabis Holdings
current capital position and access to future capital. I am
confident such a transaction would stand to dramatically enhance
shareholder value.
The acquisition transaction under consideration
has the company continuing as a publicly traded business.
North American Cannabis Holdings’ sister company, Puration, Inc.
(USOTC:
PURA) is not part of the transaction under
consideration.
Thank you,
Steven Rash
CEO
North American Cannabis
Holdings
For more information on North American Cannabis
Holdings and Puration, visit http://www.aciconglomerated.com/.
Disclaimer/Safe Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
For More Information, Contact:
Steven Rash
info@aciconglomerated.com
1-800-861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024